Revive Therapeutics Ltd. (CSE:RVV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
-0.0050 (-25.00%)
Aug 1, 2025, 3:15 PM EDT

Blueprint Medicines Ratios and Metrics

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
641614818755
Market Cap Growth
-40.00%-73.99%-89.09%-21.23%240.94%698.49%
Enterprise Value
631414316955
Last Close Price
0.010.010.040.460.590.29
PB Ratio
1.070.581.5111.716.507.39
P/TBV Ratio
---1436.1111.4828.48
Debt / Equity Ratio
0.010.000.020.030.010.06
Quick Ratio
0.010.240.650.9927.994.46
Current Ratio
0.030.340.691.0028.115.80
Return on Equity (ROE)
-50.76%-62.83%-54.36%-86.00%-111.04%-128.29%
Return on Assets (ROA)
-8.51%-16.52%-22.05%-47.58%-60.99%-48.28%
Return on Capital (ROIC)
-12.19%-22.68%-29.02%-52.90%-62.55%-52.02%
Earnings Yield
-62.71%-134.24%-39.27%-12.07%-10.74%-9.80%
FCF Yield
--78.62%-37.44%-8.85%-4.44%-4.58%
Buyback Yield / Dilution
-17.57%-12.11%-6.13%-19.54%-150.28%-67.08%
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.